Prescriber's Letter

Algorithm: <a href="/Content/Segments/PRL/2021/Apr/Mabs-for-COVID-19-Patient-Assessment-and-Referral-S2104001">“Mabs” for COVID-19: Patient Assessment and Referral
Chart: <a href="/Content/Segments/PRL/2020/Apr/Treatments-of-Interest-for-COVID-19-S2004008">Treatments of Interest for COVID-19

September 2021 Issue

You’ll hear buzz about Regen-COV (casirivimab/imdevimab), the first med to PREVENT COVID-19...

New meds and indications will lead to questions about how to treat vaginal infections...

You’ll hear that statins are no longer contraindicated in pregnancy...

Semglee (insulin glargine-yfgn U-100) will be the first “interchangeable” biosimilar.

Elderly woman waits to receive COVID-19 vaccine

Azstarys
serdexmethylphenidate/dexmethylphenidate
A stimulant for ADHD

Qelbree
viloxazine
A selective norepinephrine reuptake inhibitor for ADHD

Wegovy
semaglutide
A new formulation used for weight loss